Lenzing Weighs Heiligenkreuz Bids Against Closure Clock While Topping Up Funding
Published on 11/12/2026 at 08:20 | Editorial boerse-global.de
Lenzing has received several non-binding offers for its Heiligenkreuz site in southern Burgenland, giving the Austrian fibre maker a basis for talks on a possible sale — though the group is keeping the plant's shutdown as its fallback. The company said it will pursue negotiations only with bidders whose proposals point to an economically viable future for the site.
The number of offers submitted was not disclosed. Lenzing had recently been in contact with roughly 30 potential acquirers, a breadth of interest that keeps a sale in play provided the review turns up a workable industrial concept. Management intends to establish by the end of the year whether a sustainable sale can be reached; failing that, production is scheduled to stop at the end of the first quarter of 2027.
Three sites, three timelines
Heiligenkreuz is not the only location under review. Lenzing confirmed on 5 November that it is examining options for both Heiligenkreuz and Grimsby, with production at the UK site earmarked for wind-down by the end of 2027. The sale process for its Indonesian fibre plant is also continuing. The announced stoppages therefore run on separate schedules rather than as a single cut.
Should investors sell immediately? Or is it worth buying Lenzing?
The site-level decisions sit inside a wider restructuring. Around 2,000 jobs are to be cut across the group by the end of 2027, so the fate of any single plant is one piece of a larger reduction in headcount. Lenzing is preparing for every scenario, pursuing the sale option while holding to closure as the alternative — the framework set when the summer announcement was made.
Fresh money and a raised outlook
Alongside the plant review, Lenzing reported new financing agreements worth roughly EUR 300 million on 5 November. About half of that amount had already been contractually secured. The package comes on top of a capital increase of around EUR 300 million completed in October.
On the earnings side, the group posted adjusted EBITDA of EUR 353 million for the first nine months of 2026, with the adjusted EBITDA margin rising to 18.3%. For the full year 2026, Lenzing expects adjusted EBITDA of between EUR 430 million and EUR 460 million.
For investors, the yardstick on Heiligenkreuz is the one Lenzing has set itself: whether a bidder can flesh out a credible economic plan in the next round of talks. A viable offer would open a path away from the announced closure. Until that condition is met, the sale process carries substantial uncertainty, and the published timetable leaves little room for the discussions to drift.
Ad
Lenzing Stock: New Analysis - 12 November
Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
